US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

3  4  5  6    8    10  11  12  
Glioblastoma Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Amyotrophic Lateral Sclerosis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... emerging therapies for Amyotrophic Lateral Sclerosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating ...  |  read more...
USD 670
Brain Cancer Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Brain Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Autism Spectrum Disorder Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... emerging therapies for Autism Spectrum Disorder in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating ...  |  read more...
USD 670
Neuroblastoma Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Opioid Addiction Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Opioid Addiction in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Narcolepsy Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Brain Tumor Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Dementia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. ...  |  read more...
USD 2,000
Depression Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. ...  |  read more...
USD 2,000
Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries
10/31/2014 | published by: GBI Research
... its latest research, Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries, which provides insights into Major Depressive Disorder (MDD) ...  |  read more...
USD 4,995
Autism Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. ...  |  read more...
USD 2,000
Brain Derived Neurotrophic Factor (BDNF) Modulators -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... of the report is to establish the understanding for all the pipeline drugs that fall under Brain Derived Neurotrophic Factor (BDNF) Modulators. This report provides information on the therapeutic development based on the Brain Derived ...  |  read more...
USD 1,250
Cannabinoid Receptor Type 1 (CB1) Antagonists -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... of the report is to establish the understanding for all the pipeline drugs that fall under Cannabinoid Receptor Type 1 (CB1) Antagonists. This report provides information on the therapeutic development based on the Cannabinoid Receptor ...  |  read more...
USD 1,250
Cannabinoid Receptor Type 2 (CB2) Agonists -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... of the report is to establish the understanding for all the pipeline drugs that fall under Cannabinoid Receptor Type 2 (CB2) Agonists. This report provides information on the therapeutic development based on the Cannabinoid Receptor ...  |  read more...
USD 1,250
Global Schizophrenia Therapeutics Market 2014-2018
11/19/2014 | published by: TechNavio - Infiniti Research Ltd.
... a diminished range of expression of emotions are the characteristics of schizophrenia. The exact etiology of schizophrenia is still not known. In men, it appears in the late teens or early 20s, and in women ...  |  read more...
USD 3,000
Bipolar Disorder (Manic Depression)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs ...  |  read more...
USD 2,000
Gene Therapy Central Nervous System Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape
1/1/2015 | published by: DelveInsight
... the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Central Nervous System Report provides the target gene name, localization of ...  |  read more...
USD 3,000
High-Grade Glioma - Pipeline Review, H2 2014
12/15/2014 | published by: Global Markets Direct
... therapeutic development for High-Grade Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Global Anxiety Disorders Market 2015-2019
1/14/2015 | published by: TechNavio - Infiniti Research Ltd.
... without an identifiable cause, anxiety which persists even after the stressful condition is over, and anxiety which is out of proportion of the stressful condition indicates abnormal anxiety. However, severe and persistent anxiety can interfere ...  |  read more...
USD 2,500
Young people’s mental health
11/20/2014 | published by: Emerald Group Publishing Limited
... now. As Gandhi stated: “If we are to teach real peace in this world and if we are to carry on a real war against war, we shall have to begin with the children.” In ...  |  read more...
USD 199
Attention Deficit Hyperactivity Disorder (ADHD)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III ...  |  read more...
USD 2,000
Global Depression Therapy & Treatment Market – Depression drugs and devices, Anxiety Disorders,  SSRIs, Fischer wallace stimulator, Transcranial magnetic stimulation, Psychoanalysis, Cognitive Behavior, Psychodynamic, Electroconvulsive Pipeline Analysis,
1/16/2015 | published by: Occams Business Research & Consultancy
... Share, Growth, Trends And Forecast 2014 – 2020 Depression is a state of emotion that affects thoughts, actions and often, sleeping patterns of affected individual. Depression affects behavior in terms of loss of appetite, being ...  |  read more...
USD 4,000
Global Medical Robotics Market by Application (Orthopedic, Neurology, Laparoscopy) Type (Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton) - Segmentation and Forecast 2014-2020
12/26/2014 | published by: Occams Business Research & Consultancy
... showed tremendous growth. From surgical devices to radio imaging and treatment methods, all aspects of medicines have taken technological leaps in the recent decades, making healthcare technology one of the most lucrative markets. The demand ...  |  read more...
USD 4,000
Mania- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. ...  |  read more...
USD 2,000
3  4  5  6    8    10  11  12